Items tagged with Drug-resistant TB
The Lancet: Results of Phase 2b trial of novel TB regimen PaMZ show potential to shorten, improve TB treatment (post with simple image)
Phase 3 STAND trial launched to advance PaMZ through final stage of testing.
Leading medical organizations team up to bring new TB treatments to those in need (post with simple image)
International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
MSF issue brief: Ready, set, slow down (post with simple image)
New and promising DR-TB drugs are grabbing headlines but not reaching patients.
Access to new medications for the treatment of drug-resistant tuberculosis: Patient, provider and community perspectives (post with simple image)
Why are rates of drug-resistant TB so high in Russia? (post with simple image)
Natalya, 31, from Saint Petersburg, is being treated for a new and virulent form of an ancient disease ravaging Russia.
MSF urges EU Health Commissioner and EU Health Ministers not to skip critical regional Ministerial conference on TB next week (post with simple image)
Lack of political commitment will jeopardize momentum for stronger TB action across the region.
MSF’s DR-TB report proves 'decentralised' model is better, more cost effective (post with simple image)
The decentralised model is aimed at diagnosing and treating the majority of DR-TB patients in primary health clinics, instead of being required to be hospitalised for up to six months.
The bedaquiline donation program started on April 1 (post with simple image)
A webinar, explaining the bedaquiline donation program, will be conducted on April 14, 2015 at 8:00 am EST and can be accessed here.
Nigeria spends nearly US$1.5 million for procurement of treatment for people with multidrug-resistant TB (post with simple image)
The Nigerian government sanctioned US$1.42 million to procure quality assured Second Line Drugs (SLDs) that will be used to provide treatment for 500 multidrug-resistant TB (MDR-TB) patients. The second line drugs ordered by the government will be delivered by Stop TB Partnership’s Global Drug Facility starting June 2015.
How to access the bedaquiline donation program: step by step (post with simple image)
This is a note for implementers providing a general overview and reviewing the steps they need to take in order to access the drug.
Page 100 of 117 · Total posts: 0
←First 99 100 101 Last→